Experimental group:Shen-Qi Xiao-Tan formula

2 trials

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine

Conditions

diabetic peripheral atherosclerosis

Early Phase 1

Efficacy, safety and therapeutic mechanism of Shen-Qi Xiao-Tan Formula in the treatment of peripheral atherosclerosis in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial

RecruitingChiCTR2100047189

Hospital of Chengdu University of Traditional Chinese Medicinediabetic peripheral atherosclerosis

Start: 2021-06-11Updated: 2022-01-24

Efficacy, safety and therapeutic mechanism of Shen-Qi Xiao-Tan Formula in the treatment of peripheral atherosclerosis in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial

RecruitingITMCTR2100004933

Hospital of Chengdu University of Traditional Chinese Medicinediabetic peripheral atherosclerosis

Start: 2021-06-11Updated: 2023-02-20

Related Papers

Efficacy, safety and therapeutic mechanism of Shen-Qi Xiao-Tan formula in the treatment of peripheral atherosclerosis in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial protocol

BMC Complementary Medicine and Therapies2022-12-224 citations